Ameri Arefeh, Salmanizadeh Farzad, Keshvardoost Sareh, Bahaadinbeigy Kambiz
Kerman University of Medical Sciences, Kerman, Iran.
J Pharm Technol. 2020 Oct;36(5):171-178. doi: 10.1177/8755122520931442. Epub 2020 Jun 7.
Telepharmacy can help deliver pharmaceutical advice from an expert pharmacist to another party, such as a physician, inexperienced pharmacist, or pharmacy technician. In this study, we consider term "2-person discussions" as teleconsultation between expert pharmacists to each of the aforementioned persons. This study has 2 aims: first to prioritize 2-person discussions between the parties involved in telepharmacy services when we have limited budget and time and would like to implement the best efficient telepharmacy system. Second to examine the barriers and benefits of implementing a telepharmacy. The research population included 40 pharmacists working in Kerman pharmacies (Iran). Their viewpoints were evaluated using a valid and reliable researcher-made questionnaire. The first part of the questionnaire focused on professional-demographic information, while the second part addressed the most important 2-person discussions and also asked about barriers to and benefits of implementing telepharmacy. The findings indicate that the following 2-person discussions are priority for implementation: physician-pharmacist, pharmacist-hospital ward, and pharmacist-pharmacist. Payment and reimbursement issues and lack of access to information technology infrastructure were among the most important barriers. Efficient training about medicine usage, drug-drug interactions, and adverse effects was the most important benefit of telepharmacy. In this study, pharmacists' first priority regarding who to involve in a 2-person telepharmacy consultation was to establish a long-distance connection between physicians and pharmacists. This finding indicates that the pharmacists were more interested in providing teleconsultation services to physicians and other pharmacists rather than communicating with pharmaceutical technicians.
远程药学可以帮助将专业药剂师的药学建议传递给另一方，比如医生、经验不足的药剂师或药房技术员。在本研究中，我们将“两人讨论”这一术语视为专家药剂师与上述每个人之间的远程会诊。本研究有两个目标：首先，当我们预算和时间有限且希望实施最高效的远程药学系统时，对参与远程药学服务的各方之间的两人讨论进行优先级排序。其次，研究实施远程药学的障碍和益处。研究人群包括在克尔曼药房（伊朗）工作的40名药剂师。使用一份有效且可靠的由研究人员编制的问卷对他们的观点进行评估。问卷的第一部分聚焦于专业人口统计学信息，而第二部分涉及最重要的两人讨论，并询问了实施远程药学的障碍和益处。研究结果表明，以下两人讨论是实施的优先事项：医生 - 药剂师、药剂师 - 医院病房以及药剂师 - 药剂师。支付和报销问题以及缺乏信息技术基础设施接入是最重要的障碍。关于药物使用、药物相互作用和不良反应的高效培训是远程药学最重要的益处。在本研究中，药剂师对于在两人远程药学会诊中涉及谁的首要优先事项是在医生和药剂师之间建立远程连接。这一发现表明，药剂师对向医生和其他药剂师提供远程会诊服务比与药房技术员沟通更感兴趣。
